In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

King raises $165mm

Executive Summary

King Pharmaceuticals (acquires and inlicenses branded pharmaceuticals in niche markets) netted $165.5mm in a follow-on offering of 4mm common shares at $41.38 each. All of the shares were purchased by Donaldson, Lufkin, and Jenrette, which will offer them for resale.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies